Table 1

Accelerometry studies supporting the Prospective Physical Activity, Sitting, and Sleep consortium (ProPASS)

Main study Name/countryLeading institutionGeographical coverage of the studyParticipants (n)SexPopulation/age range (accelerometry measurement)Accelerometry deviceYears (accelerometry measurement)
Australian Longitudinal Study on Women’s Health/ AustraliaThe University of Queensland and The University of SydneyAustralia(target) ≈3250WomenGeneral population/45–50 yearsActivPAL3 and ActivPAL4 micro2019–2020
1970 British Birth Cohort Study/UKLoughborough University and University College LondonUK≈5500BothGeneral population/47–49 yearsActivPAL3 micro2016–2018
Copenhagen City Heart Study/Denmark10 Frederiksberg Hospital, CopenhagenTwo districts of Copenhagen≈2000BothGeneral population/18 years or olderActigraph GT3X2011–2015
Danish PHysical ACTivity cohort with Objective measurements (DPHACTO) Study11/DenmarkNational Research Centre for the Working Environment, CopenhagenDenmark≈1000BothWorkers in manufacturing, cleaning and transportation companies/18–67 yearsActigraph GT3X2012–2014
Danish Observational Study of Eldercare work and musculoskeletal disorderS (DOSES)12 Study/DenmarkNational Research Centre for the Working Environment, CopenhagenGreater Copenhagen region≈500BothEldercare workers/18–67 yearsActigraph GT3X2013–2014
Finnish Retirement and Aging Study (FIREA)/Finland13 University of TurkuSouthwest Finland≈280BothGeneral population/occupational cohort/59–65 years, 60–64 yearsActivPAL32015–2020
Health 2016 Study/DenmarkCentre for Clinical Research and Prevention, FrederiksbergWestern part of Greater Copenhagen≈800BothGeneral population/18–69 yearsAxivity2016–2017
The Nord-Trøndelag Health Study (HUNT 4)14/NorwayNorwegian University of Science and TechnologyNorthern part of Trøndelag region≈40 000BothGeneral population/18 years or olderAxivity 32017–2019
The Maastricht Study15/The NetherlandsMaastricht UniversitySouth of The Netherlands≈9000BothGeneral population (oversampling of people with type 2 diabetes)/40–75 yearsActivPAL32010–2019
Swedish CArdioPulmonary bioImage Study (SCAPIS)16 Ad-On Gothenburg/SwedenUniversity of GothenburgGothenburg region≈500BothGeneral population/50–64 yearsAxivity AX32017
Swedish CArdioPulmonary bioImage Study (SCAPIS)16 Ad-On Umeå/SwedenUmeå UniversityUmeå region≈2500BothGeneral population/50–64 yearsActivPAL32016–2018
Swedish CArdioPulmonary bioImage Study (SCAPIS) Ad-On Uppsala16/SwedenUppsala UniversityUppsala region≈5000BothGeneral population/50–64 yearsAxivity AX32015–2018